An Investigational New Drug (IND) is a drug or biological drug that has not been approved for general use by the FDA. It is used in a clinical trial to investigate its safety and efficacy. The term ...
The last decade has seen a “dramatic increase” in investigational new drug (IND) applications for cannabis-derived products, according to the U.S. Food and Drug Administration. In a paper ...
U.S.-based PleoPharma announced yesterday that the FDA has granted it a fast-track designation for PP-01, which is a new investigational drug for cannabis withdrawal syndrome. If approved ...
The road map will specify the timeline for filing investigational new drug applications for each drug in the pipeline. Updates will focus on two ADC-based cancer drugs, CT-P70 and CT-P71 ...
The University of Chicago will receive up to $130 million in funding over the next 10 years as part of a new drug research ...
当前正在显示可能无法访问的结果。
隐藏无法访问的结果